In short. The best evidence for 3D planning concerns bone position in jaw and reconstructive surgery, not the prediction of how a face will look.
Key points
- That a plan can be reproduced and transferred is a real and useful result, and it is much narrower than the claims made around it.
- It says nothing about soft tissue, nothing about how a result ages, and nothing about whether the operation was a good idea in the first place.
The evidence for three-dimensional planning is not evenly spread, and the pattern is consistent: it is strongest where a bone has to end up in a particular place, and weakest where the question is what a person will look like. Reading the studies by outcome rather than by procedure makes the pattern clear.
Bone position and its transfer
The central finding is that a plan generated from imaging reproduces a bone position more consistently than planning done freehand or from plain film, and that a guide manufactured from that plan locates the position on the day. This has been shown most clearly in jaw surgery and in reconstruction, where the anatomy is complex, the movement has to be right in more than one plane, and the achieved position can be measured afterwards on imaging. It is a solid finding and it is about geometry.
Planning and the operation itself
A secondary group of studies looks at what planning does to the operation rather than to the bone: operating time, the number of times a plan is adjusted mid-procedure, and how often a surgeon deviates from what was intended. These results are limited rather than established. The series are small, they come from single centres, the planning systems differ between them, and a shorter operation in one surgeon’s hands is not the same finding as a better outcome for a patient.
The strongest finding is the narrowest one
That a plan can be reproduced and transferred is a real and useful result, and it is much narrower than the claims made around it. It says nothing about soft tissue, nothing about how a result ages, and nothing about whether the operation was a good idea in the first place.
Where the evidence thins out
Studies that report how a result looks, or how satisfied a person is, are far fewer and much weaker. Satisfaction is collected with different instruments or not at all, follow-up is often short, and a good result at six months is not the same claim as a good result at five years. Patient-specific implants are emerging rather than established: the manufacturing is regulated and the fit is demonstrable, but whether the long-term result is better than a well-chosen standard implant is not settled by the studies that exist.
What none of it establishes
No body of evidence shows that planning lowers the overall complication rate, and none shows that a rendered image predicts how someone will look. Those claims are made regularly in the same confident register as the reproducible-bone-position finding, and they do not come from the same kind of evidence.
How to weigh a study you are shown
- What outcome was measured — a bone position, an operating time, or how the person looks?
- How many people, over how long, and was anything compared against a group planned differently?
- Does the conclusion being drawn to me go further than the outcome that was actually measured?
Grading the evidence by outcome is what keeps a strong narrow finding from being stretched over a wide claim.
Frequently asked questions
Which use of 3D planning has the strongest evidence?
Reproducing a planned bone position in jaw and reconstructive surgery, and transferring it with a manufactured guide. That finding is consistent across studies and it matches how the devices are cleared. It is also a finding about bone, not about appearance.
Why is the evidence mostly about bone position?
Because bone position is measurable from imaging, so a study can compare what was planned with what was achieved. How a face looks afterwards, and whether the person is satisfied, are harder to measure and are collected inconsistently, so far fewer studies report them.
Is a patient-specific implant better than a standard one?
That is emerging rather than established. A patient-specific implant fits a plan rather than being selected from a range, and the manufacturing is regulated. Whether that translates into a better long-term result than a well-chosen standard implant is a question the current studies do not settle.
Risks & Limitations
- A rendered simulation is an illustration of a plan, not a prediction of how a face will look.
- A plan built on a poor scan, or on a boundary traced wrongly, is a precise plan of the wrong shape.
- Planning software, printed guides and patient-facing images sit in three regulatory classes, and one approval is not another.
- No study has shown that planning lowers the overall complication rate.
- A scan records structure in one posture, and does not replace an examination of how tissue behaves.
When to Seek Care
- A wound that is opening, or spreading redness, warmth or discharge — contact the service that holds your records.
- Fever, or pain that is worsening rather than settling after an operation.
- Bleeding that does not stop with gentle pressure.
- If you were shown a simulation and are unsure what it represented, ask the team that showed it to you, and ask to see the plan behind it.
References & Further Reading
- U.S. Food and Drug Administration (FDA) — cleared and approved surgical planning software, guides and patient-specific implants
- European Medicines Agency (EMA) and national competent authorities — medical device regulation and custom-made device guidance
- National Medical Products Administration (NMPA, China) — approved medical devices and their indications
- National Institute for Health and Care Excellence (NICE, UK) — guidance on imaging and surgical planning
- Cochrane Library — systematic reviews of computer-assisted surgery
This page is patient education, not medical advice, and it does not cite individual studies. It reviews evidence and regulation; it is not a booking page and does not recommend a treatment. Discuss your own case with a qualified clinician. To ask a question about this review, see Contact & Consultation.